Aphria Insiders to Depart Liberty Health Sciences Board of Directors

TORONTOJan. 8, 2019 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, today announced that Vic Neufeld and John Cervini will be stepping down from the Board of Directors, effective January 31, 2019. The Board is continuing its search for two qualified and independent board members.

“This announcement dovetails with Liberty’s commitment to strengthening its corporate governance practices,” said George Scorsis, CEO of Liberty Health Sciences. “We are focused on enhancing the independence of our Board of Directors and have initiated a search to identify candidates with the appropriate backgrounds to support the next stage of our Company’s growth. We would like to thank both Vic and John for providing their invaluable knowledge when we commenced this journey and for continuing to add value throughout Liberty’s most important years. We wish them the best.”

Liberty has also retained Miller Thomson LLP as its Canadian legal counsel. Miller Thomson will provide advice on, among other things, Canadian corporate governance practices and securities law compliance matters.

About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.       

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “believe”, “plan”, “intend” or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Liberty Health Sciences Inc.

For further information: Media Contacts: Dwain Schenck, 203-223-5230, dwain@schenckstrategies.com; Stephanie Kubacki, Vice-President, Marketing, 415-830-7337, skubacki@libertyhealthsciences.com